Lorenzo
Redondo Collazo
Massachusetts General Hospital
Boston, Estados UnidosPublicacións en colaboración con investigadores/as de Massachusetts General Hospital (1)
2022
-
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Journal of Neurodevelopmental Disorders, Vol. 14, Núm. 1